激光辅助经皮免疫小鼠诱导抑制Spike/ACE2结合的抗体
该研究将SARS-CoV-2 Spike蛋白S1亚单位通过激光微孔递送至BALB/c小鼠皮肤,联合或不联合CpG-ODN1826或LT-B佐剂。经皮免疫诱导血清IgG滴度达1:3200,联合LT-B或CpG可分别提升5至10倍,血清可抑制Spike蛋白与受体ACE2结合。
要点
- 激光辅助经皮免疫可诱导针对SARS-CoV-2 Spike蛋白的血清IgG应答。
- 联合LT-B或CpG佐剂可分别将IgG滴度提升5倍或10倍。
- 免疫血清可抑制Spike蛋白与ACE2受体的结合。
核心结论
- 经激光微孔递送重组Spike蛋白至皮肤可能成为COVID-19疫苗的替代接种途径。
研究设计与样本
- 研究将SARS-CoV-2 Spike蛋白S1亚单位经激光生成微孔递送至BALB/c小鼠皮肤,联合或不联合CpG-ODN1826或LT-B。
主要发现
- 经皮免疫诱导血清IgG滴度达1:3200。
- 联合LT-B可将IgG滴度提升5倍,联合CpG可提升10倍。
- 免疫血清可抑制Spike蛋白与受体ACE2的结合。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The skin represents an attractive target tissue for vaccination against respiratory viruses such as SARS-CoV-2. Laser-facilitated epicutaneous immunization (EPI) has been established as a novel technology to overcome the skin barrier, which combines efficient delivery via micropores with an inherent adjuvant effect due to the release of danger-associated molecular patterns. Here we delivered the S1 subunit of the Spike protein of SARS-CoV-2 to the skin of BALB/c mice via laser-generated micropores with or without CpG-ODN1826 or the B subunit of heat-labile enterotoxin of E.coli (LT-B). EPI induced serum IgG titers of 1:3200 that could be boosted 5 to 10-fold by co-administration of LT-B and CpG, respectively. Sera were able to inhibit binding of the spike protein to its receptor ACE2. Our data indicate that delivery of recombinant spike protein via the skin may represent an alternative route for vaccines against Covid-19.
引用
- Scheiblhofer S, Drothler S, Braun W, et al. Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding. Vaccine. 2021. PMID: 34226102. doi:10.1016/j.vaccine.2021.06.068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。